Background
Purpose
Methods
Results
Conclusions
Background
Methods
Study Population
Data Sources
Potential Adverse Events
Study Design and Analyses
Self-controlled risk interval design for signal detection—binomial-based MaxSPRT
Current versus historical comparison for signal detection—Poisson-based and conditional MaxSPRT
Medical Record Reviews
Signal Refinement
Results
Vaccine Doses


Rapid Cycle Analysis of Adverse Events Following Immunization

Signal Refinement for Bell's Palsy
Discussion
Supplementary data
- Appendix A and B
References
- Perceived seriousness of seasonal and A(H1N1) influenzas, attitudes toward vaccination, and vaccine uptake among U.S. adults: does the source of information matter?.Prev Med. 2010; 51: 185-187
- Illness after influenza vaccination reported through a nationwide surveillance system, 1976–1977.Am J Epidemiol. 1980; 111: 270-278
Salmon D, Akhtar A, Mergler M, et al. Monitoring immunization safety for the pandemic 2009–2010 H1N1 influenza vaccination program. Pediatrics; In press.
- Federal plans to monitor immunization safety for the pandemic 2009 H1N1 influenza vaccination program.
- Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink project.Am J Epidemiol. 2010; 171: 177-188
- The Vaccine Safety Datalink project.Pharmacoepidemiol Drug Saf. 2001; 10: 403-406
- The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA.Bull World Health Organ. 2000; 78: 186-194
- Real-time vaccine safety surveillance for the early detection of adverse events.Med Care. 2007; 45: S89-S95
- Guillain-Barré syndrome following vaccination in the National Influenza Immunization Program, U.S., 1976-1977.Am J Epidemiol. 1979; 110: 105-123
- Influenza vaccination and Guillain Barré syndrome.Clin Immunol. 2003; 109 (author reply 360–51): 359
- Guillain-Barré syndrome following influenza vaccination.JAMA. 2004; 292: 2478-2481
- Guillain-Barré syndrome after influenza vaccination in adults: a population-based study.Arch Intern Med. 2006; 166: 2217-2221
- Guillain-Barré syndrome after vaccination in U.S.: a report from the CDC/FDA vaccine adverse event reporting system.Vaccine. 2007; 25: 5253-5255
- An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines.Am J Epidemiol. 1984; 119: 841-879
- Influenza vaccine and neurological adverse events: VAERS 7/1990 - 1/2003.(Paper presented at Immunization Safety Review: Influenza Vaccine and Possible Neurological Complications; 2003; Washington DC)
- Post-influenza vaccine chronic inflammatory demyelinating polyneuropathy.Age Ageing. 2008; 37: 229-230
- Optic neuritis after influenza vaccination.Am J Ophthalmol. 1997; 124: 703-704
- Neurologic complications associated with influenza vaccination: two adult cases.Intern Med. 2003; 42: 191-194
- Severe vasculitic neuropathy following influenza vaccination.J Neurol Neurosurg Psychiatry. 2004; 75: 1507-1508
- Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990–2003.Pediatrics. 2005; 115: 453-460
- Meningoencephalitis syndrome following influenza vaccination.J Neurol. 1978; 217: 219-222
- A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)—U.S., 1991–2001.Pharmacoepidemiol Drug Saf. 2004; 13: 505-510
- Bell's palsy associated with influenza vaccination: two case reports.Vaccine. 2007; 25: 2839-2841
- Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland.N Engl J Med. 2004; 350: 896-903
- Acute cerebellar ataxia after influenza vaccination with recurrence and marked cerebellar atrophy.Tohoku J Exp Med. 1989; 158: 95-103
- Risk of anaphylaxis after vaccination of children and adolescents.Pediatrics. 2003; 112: 815-820
- Anaphylaxis from the influenza virus vaccine.Int Arch Allergy Immunol. 2008; 146: 85-88
- Adverse events reported following live, cold-adapted, intranasal influenza vaccine.JAMA. 2005; 294: 2720-2725
- Urticaria subsequent to administration of influenza vaccine.South Med J. 1979; 72: 1334-1335
- Histopathologic and immunohistochemical features of fatal influenza virus infection in children during the 2003–2004 season.Clin Infect Dis. 2006; 43: 132-140
- Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)—U.S., 1991-2001.MMWR Surveill Summ. 2003; 52: 1-24
- Side effects associated with influenza vaccination in healthy working adults.Arch Intern Med. 1996; 156: 1546-1550
- Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old.JAMA. 2006; 296: 1990-1997
- Post-marketing safety evaluation of a tetanus toxoid, reduced diptheria toxoid and 3-component acellular pertussis vaccine administered to a cohort of adolescents in a United States health maintenance organization.Pediatr Infect Dis J. 2010; 29: 613-617
- Day-to-day reactogenicity and the healthy vaccinee effect of measles-mumps-rubella vaccination.Pediatrics. 2000; 106: E62
- Near real-time vaccine safety surveillance with partially accrued data.Pharmacoepidemiol Drug Saf. 2011; (In press)
- A maximized sequential probability ratio test for drug and vaccine safety surveillance.Seq Anal. 2011; 30: 58-78
- A conditional maximized sequential probability ratio test for pharmacovigilance.Stat Med. 2010; 29: 284-295
- Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data.
Brookings Institution. Paper presented at Methods for Signal Refinement in Active Medical Product Surveillance; 2010; Washington DC.
- A spatial scan statistic.Commun Stat Theory Methods. 1997; 6: 1481-1496
- SaTScan(TM) v8.1.1: Software for the spatial and space–time scan statistics [computer program].Information Management Services [RH3]Inc, Silver Spring MD2010
- Influenza vaccination and mortality: differentiating vaccine effects from bias.Am J Epidemiol. 2009; 170: 650-656
- Bell's palsy and parenteral inactivated influenza vaccine.Hum Vaccin. 2006; 2: 110-112
- Effects of climate, latitude, and season on the incidence of Bell's palsy in the U.S. Armed Forces, October 1997 to September 1999.Am J Epidemiol. 2002; 156: 32-39
Yih WK, Kulldorff M, Fireman BH, et al. Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project. Pediatrics; In press.
- Accuracy of data on influenza vaccination status at four Vaccine Safety Datalink sites.Am J Prev Med. 2009; 37: 552-555
- Accuracy of influenza vaccination status in a computer-based immunization tracking system of a managed care organization.Vaccine. 2010; 28: 5254-5259
- Final Estimates for 2009–10 Seasonal Influenza and Influenza A (H1N1) 2009 Monovalent Vaccination Coverage – U.S., August 2009 through May, 2010.
- Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008.MMWR Recomm Rep. 2008; 57: 1-60
Article Info
Footnotes
This activity is available for CME credit. See page A3 for information.